Hints and tips:
...From our perspective the strategic rationale of the deal would be limited: GILD’s is currently a similarly sized pharma business to AZN (2020E $25bn on our US colleague’s estimates vs. $26bn on ours for...
...Pfizer is the latest US group to take this path, following in the steps of Burger King, Liberty Global and Medtronic among others....
International Edition